Latest Period
Q2 2026
Security Snapshot
FibroBiologics, Inc. - Common Stock (FBLG) Institutional Ownership
CUSIP: 31573L204
13F Institutional Holders and Ownership History from Q1 2026 to Q2 2026
Institutions Reporting
16
Shares (Excl. Options)
284,937
Price
$0.95
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- FBLG on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 284,937
- Total 13F value
- $269,614
- Portfolio coverage rank
- 0%
- Share change
- +64,445
- Value change
- +$54,150
- Number of holders
- 16
- Shares outstanding
- 8,400,120
- SEC-reported price per share
- $1.44
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- FBLG - FibroBiologics, Inc. - Common Stock is tracked under CUSIP 31573L204.
- 16 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 16 to 16 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $291,062 to $269,614.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 16 institutions filings for Q2 2026.
Security key
31573L204
Latest holder period
Q2 2026
13F holders
16
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
FBLG full holder history
FibroBiologics, Inc. SEC filings
FibroBiologics, Inc. company facts
FibroBiologics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 31573L204:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
FBLG
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 10% | $635,520 | 738,977 | Armistice Capital, LLC | 30 Jun 2026 | |||
| Khoja Hamid | 7.5% | $907,213 | 630,009 | Hamid Khoja | 15 Sep 2026 |
As of 30 Jun 2026, 16 institutional investors reported holding 284,937 shares of FibroBiologics, Inc. - Common Stock (FBLG). This represents 3.4% of the company’s total 8,400,120 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Latest
Q2 2026
Rows shown
1-2 of 2